CLOSE
MENU
A female doctor explains a procedure to a patient
A female doctor explains a procedure to a patient

Steroids, Artificial Tears & Irrigation Formulations

Explore Our Product Portfolio:

Please refer to Summary of Product Characteristics before prescribing. Further information about this product can be requested from the Marketing Authorisation Holder or may be found in the Summary of Product Characteristics.

Minims® Prednisolone Sodium Phosphate 0.5%
Minims® Prednisolone Sodium Phosphate 0.5%

Minims® Prednisolone Sodium Phosphate 0.5% w/v, Eye Drops, Solution

Composition

Prednisolone Sodium Phosphate 0.5% w/v

Indication:

Non-infected inflammatory conditions of the eye.

Click here for Prescribing Information link-out icon

Minims® Dexamethasone sodium phosphate 0.1%
Minims® Dexamethasone sodium phosphate 0.1%

Minims® Dexamethasone sodium phosphate 0.1% w/v, Eye Drops, Solution

Composition

Dexamethasone sodium phosphate Ph Eur 0.1% w/v

Indication:

Non-infected, steroid responsive, inflammatory conditions of the eye.

Click here for Prescribing Information link-out icon

Minims® Saline 5% w/v, Eye Drops, Solution
Minims® Saline 5% w/v, Eye Drops, Solution

Minims® Saline 0.9% w/v, Eye Drops, Solution

Composition

Sodium Chloride 0.9% w/v.

Indication:

Topical ocular irrigating solution.

Click here for Prescribing Information link-out icon

Minims® Artificial Tears 0.35
Minims® Artificial Tears 0.35

Minims® Artificial Tears 0.35% w/w + 0.44% w/w, Eye Drops, Solution

Composition

0.35% w/w Sodium Chloride with Hyetellose 0.44% w/w

Indication:

For the relief of dry eye syndromes associated with deficient tear secretion. One or two drops instilled into the affected eye three or four times daily, or as required.

Click here for Prescribing Information link-out icon

Reporting side effects:

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bausch + Lomb at: ukmedinformation@bausch.com or call +044 (0) 2087812991

August 2024/MIN.0010.UK.23